Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cannabidiol pain:

Search results

Items: 1 to 20 of 269

1.

Development of a validated method for the qualitative and quantitative analysis of cannabinoids in plant biomass and medicinal cannabis resin extracts obtained by super-critical fluid extraction.

Elkins AC, Deseo MA, Rochfort S, Ezernieks V, Spangenberg G.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 30;1109:76-83. doi: 10.1016/j.jchromb.2019.01.027. [Epub ahead of print]

PMID:
30738340
2.

An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine.

Urits I, Borchart M, Hasegawa M, Kochanski J, Orhurhu V, Viswanath O.

Pain Ther. 2019 Feb 5. doi: 10.1007/s40122-019-0114-4. [Epub ahead of print] Review.

PMID:
30721403
3.

Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting.

Mortimer TL, Mabin T, Engelbrecht AM.

Future Oncol. 2019 Feb 5. doi: 10.2217/fon-2018-0530. [Epub ahead of print]

PMID:
30720344
4.

Cannabinoid Ligands Targeting TRP Channels.

Muller C, Morales P, Reggio PH.

Front Mol Neurosci. 2019 Jan 15;11:487. doi: 10.3389/fnmol.2018.00487. eCollection 2018. Review.

5.

Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review.

Mohiuddin MM, Mizubuti G, Haroutounian S, Smith S, Campbell F, Park R, Gilron I.

JMIR Res Protoc. 2019 Jan 28;8(1):e11637. doi: 10.2196/11637.

6.

US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions.

Kogan L, Schoenfeld-Tacher R, Hellyer P, Rishniw M.

Front Vet Sci. 2019 Jan 10;5:338. doi: 10.3389/fvets.2018.00338. eCollection 2018.

7.

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer.

Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L.

Biomed Res Int. 2018 Dec 4;2018:1691428. doi: 10.1155/2018/1691428. eCollection 2018. Review.

8.

An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.

van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M.

Pain. 2018 Dec 20. doi: 10.1097/j.pain.0000000000001464. [Epub ahead of print]

PMID:
30585986
9.

Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.

Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E.

Mult Scler Relat Disord. 2019 Jan;27:383-390. doi: 10.1016/j.msard.2018.11.022. Epub 2018 Nov 20.

PMID:
30502644
10.

Impact of recreational and medicinal marijuana on surgical patients: A review.

Bakshi C, Barrett AM.

Am J Surg. 2018 Nov 14. pii: S0002-9610(18)31123-1. doi: 10.1016/j.amjsurg.2018.10.053. [Epub ahead of print] Review.

PMID:
30471810
11.

A UHPLC-MS/MS method for the quantification of Δ9-tetrahydrocannabinol and cannabidiol in decoctions and in plasma samples for therapeutic monitoring of medical cannabis.

Barco S, Fucile C, Manfredini L, De Grandis E, Gherzi M, Martelli A, Tripodi G, Mattioli F, Cangemi G.

Bioanalysis. 2018 Nov 6. doi: 10.4155/bio-2018-0184. [Epub ahead of print]

PMID:
30412688
12.

Cannabis Therapeutics and the Future of Neurology.

Russo EB.

Front Integr Neurosci. 2018 Oct 18;12:51. doi: 10.3389/fnint.2018.00051. eCollection 2018.

13.

Medical Use of Cannabinoids.

Fraguas-Sánchez AI, Torres-Suárez AI.

Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Review.

PMID:
30374797
14.

Quantification of Eight Cannabinoids Including Cannabidiol in Human Urine Via Liquid Chromatography Tandem Mass Spectrometry.

Scheidweiler KB, Barnes AJ.

Methods Mol Biol. 2019;1872:11-22. doi: 10.1007/978-1-4939-8823-5_2.

PMID:
30350275
15.

Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases.

Schräder NHB, Duipmans JC, Molenbuur B, Wolff AP, Jonkman MF.

Br J Dermatol. 2018 Oct 22. doi: 10.1111/bjd.17341. [Epub ahead of print]

PMID:
30347109
16.

Survey of Australian psychiatrists' and psychiatry trainees' knowledge about and attitudes towards medicinal cannabinoids.

Jacobs NI, Montebello M, Monds LA, Lintzeris N.

Australas Psychiatry. 2019 Feb;27(1):80-85. doi: 10.1177/1039856218803675. Epub 2018 Oct 9.

PMID:
30298754
17.

Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol.

Kenyon J, Liu W, Dalgleish A.

Anticancer Res. 2018 Oct;38(10):5831-5835. doi: 10.21873/anticanres.12924.

PMID:
30275207
18.

Cannabinoid Delivery Systems for Pain and Inflammation Treatment.

Bruni N, Della Pepa C, Oliaro-Bosso S, Pessione E, Gastaldi D, Dosio F.

Molecules. 2018 Sep 27;23(10). pii: E2478. doi: 10.3390/molecules23102478. Review.

19.

Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol.

Greene NZ, Wiley JL, Yu Z, Clowers BH, Craft RM.

Psychopharmacology (Berl). 2018 Nov;235(11):3289-3302. doi: 10.1007/s00213-018-5036-z. Epub 2018 Sep 20.

PMID:
30238130
20.

Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain.

Mondello E, Quattrone D, Cardia L, Bova G, Mallamace R, Barbagallo AA, Mondello C, Mannucci C, Di Pietro M, Arcoraci V, Calapai G.

J Pain Res. 2018 Sep 6;11:1761-1767. doi: 10.2147/JPR.S166617. eCollection 2018.

Supplemental Content

Loading ...
Support Center